Graves Disease
📧 Sign up to get email alerts when something new happens for Graves Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease [Phase 2]
Phase 2 proof-of-concept study evaluating batoclimab for Graves' disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) [Phase 2]
Phase 2 long-term extension study update for IMVT-1402 in adults with Graves' Disease is currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) [Phase 2]
This clinical trial update describes a Phase 2 long-term extension study of IMVT-1402 in adults with Graves' disease, currently enrolling by…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease [Phase 2]
Batoclimab was evaluated in a Phase 2 proof-of-concept study for Graves' disease, and the trial status is reported as completed. The provide…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study [NA]
This completed case-control study investigates the prevalence of circulating parvovirus genome in patients recently diagnosed with Graves' d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz [Phase 2]
A Phase 2 study evaluating WP1302 to prevent relapse after methimazole withdrawal in Graves' disease is suspended.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Efficacy of Methimazole Dosing Algorithm
A terminated clinical trial evaluating a methimazole dosing algorithm for Graves' disease; no definitive efficacy data is provided in the up…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy? [Phase 3]
A Phase 3 trial investigated whether potassium iodide (SSKI) can reduce vascularity in Graves' thyroidectomy; the study was terminated and r…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Effects of Vitamin D Supplementation on Muscle Function Among Grave's Disease Patients [NA]
This clinical trial update reports completion of a study evaluating whether vitamin D supplementation improves muscle function in patients w…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease. [Phase 4]
Phase 4 clinical trial evaluating preoperative Lugol solution in patients with Graves-Basedow disease (hyperthyroidism).
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Graves' Disease Remission Study: MycoMeth Combo [Phase 2, Phase 3]
Phase 2/3 clinical trial update for MycoMeth Combo in Graves' disease currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease [Phase 4]
A Phase 4 clinical trial update assessing how different treatment schemes affect regulation and relapse in Graves' disease, currently recrui…
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy [Phase 2]
Phase 2 clinical trial update evaluating doxycycline for mild thyroid-associated ophthalmopathy (Graves-related eye disease).
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis [Phase 3]
Phase 3 trial update examining the effect of hyperthyroidism and its treatment on an early marker of atherosclerosis in Graves' disease.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment [Phase 4]
Phase 4 diagnostic accuracy study evaluating indocyanine green for assessing parathyroid perfusion in thyroid surgery is completed.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients [Phase 2]
Phase 2 trial evaluating oral alfacalcidol and its effects on maturation of dendritic cells in Graves' disease.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Early Levothyroxine Post Radioactive Iodine [Phase 2, Phase 3]
Clinical trial update on early levothyroxine after radioactive iodine for Graves' disease reported completion and results posting.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Bupivacaine Injection of Eye Muscles to Treat Strabismus [Phase 2, Phase 3]
Clinical trials are evaluating bupivacaine injections into eye muscles for treating strabismus across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy [Phase 1]
Phase 1 clinical trial update for ATX-GD-59 in Graves disease patients not treated with anti-thyroid therapy has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Liver Function After Intravenous Methylprednisolone Administration [Phase 4]
A Phase 4 clinical trial update evaluating liver function following intravenous methylprednisolone administration in Graves disease and Grav…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Clinical trial update on anti-IGF-1R antibodies for Graves' disease and Graves' ophthalmopathy; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Impact of Intravenous Methylprednisolone Treatment on Blood Pressure
The clinical trial evaluating intravenous methylprednisolone's impact on blood pressure in Graves disease and Graves ophthalmopathy has comp…
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Coagulation After Intravenous Methylprednisolone Administration
The document summarizes the completed clinical trial evaluating coagulation effects after intravenous methylprednisolone administration in p…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease [Phase 2]
Phase 2 trial update evaluating CFZ533 for Graves' Disease has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
A clinical trial evaluating pulse rate–monitoring activity trackers in thyrotoxicosis has completed, including participants with Graves' dis…